Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule are provided. Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule and at least one anti-angiogenic agent are provided.
申请公布号
WO2014190147(A2)
申请公布日期
2014.11.27
申请号
WO2014US39129
申请日期
2014.05.22
申请人
FIVE PRIME THERAPEUTICS, INC.;GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
发明人
BELLOVIN, DAVID;BAKER, KEVIN;BRENNAN, THOMAS;PANDITE, ARUNDATHY NIRMALINI;MOOKERJEE, BIJOYESH;DEYOUNG, MAURICE P.;KUMAR, RAKESH
